ACTU — ACTUATE THERAPEUTICS INCORPORATED

Ownership history in Gleason Group, Inc.  ·  3 quarters on record

This page tracks every 13F SEC filing in which Gleason Group, Inc. reported a position in ACTUATE THERAPEUTICS INCORPORATED (ACTU). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.01% (2025 Q3)
Avg. % of fund
0.01%
First filed
2025 Q2
Last filed
2025 Q4
Quarters held
3
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 UNCHANGED 19,028 — 0% 0.01% $116K $6.12
2025 Q3 UNCHANGED 19,028 — 0% 0.01% $127K $6.69
2025 Q2 INITIATED 19,028 — — 0.01% $116K $6.11
% of Fund (quarterly)    ACTU price (monthly, adj. close)

Other funds also holding ACTU

As of 2025 Q4 — sorted by position size

Voss Capital, LP 3Y 0.38% ABS Direct Equity Fund LLC 0.05% Rock Creek Group, LP 3Y 7Y 0.01% SFMG, LLC 3Y 7Y 0.01% BRIDGEWAY CAPITAL MANAGEMENT, LLC 3Y 7Y 0.0% NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 3Y 7Y 0.0% Tower Research Capital LLC (TRC) 3Y 7Y 0.0% Ameritas Investment Partners, Inc. 3Y 7Y 0.0% GEODE CAPITAL MANAGEMENT, LLC 3Y 7Y 0.0% RHUMBLINE ADVISERS 3Y 7Y 0.0%
← Back to Gleason Group, Inc. Holdings